期刊文献+

RNA干扰Cdx2基因沉默对人胃癌裸鼠耐药模型Survivin和C-myc表达的影响

Effects of RNAi-mediated Cdx2 gene silencing on the expression of Survivin and C-myc in nude mice model of human gastric cancer
下载PDF
导出
摘要 目的观察携带人尾型同源盒转录因子2(Cdx2)基因沉默的重组慢病毒颗粒(Cdx2-RNAi-LV)对人胃癌耐顺铂细胞SGC-7901/DDP裸鼠皮下移植瘤中Survivin和C-myc表达的影响。方法建立人胃癌耐顺铂细胞SGC-7901/DDP裸鼠皮下移植瘤模型,36只裸鼠随机分成3组(n=12):PBS组、LV-RNAi组、Cdx2-RNAi-LV组;各组瘤体内分别注射磷酸盐缓冲液、慢病毒颗粒(0.5×108TU/ml)、含Cdx2基因重组慢病毒颗粒(0.5×108TU/ml)相应药物100μl,1次/3d,共6次;同时所有裸鼠腹腔注射药物顺铂(25mg/kg),隔天1次,共10次;注射Cdx2-RNAi-LV病毒颗粒第20天后脱颈椎法处死裸鼠,完整切取肿瘤组织,并应用PT-PCR和Westernblot技术检测移植瘤中Survivin和C-myc基因的表达。结果 Cdx2-RNAi-LV组、LV-RNAi组和PBS组的细胞均有Survivin、C-myc的mRNA和蛋白的表达,但各组细胞对应的Survivin、C-myc的mRNA和蛋白的表达水平有差别;Cdx2-RNAi-LV组Survivin、C-myc的mRNA和蛋白的表达量较PBS组和LV-RNAi组明显下调(P<0.05),而PBS组和LV-RNAi组比较差异无统计学意义(P>0.05)。结论 Cdx2基因沉默重组慢病毒颗粒瘤内注射下调人胃癌耐顺铂细胞裸鼠移植瘤Survivin和C-myc表达,可能是Cdx2基因沉默逆转肿瘤的耐药性机制之一。 Objective To investigate the effect of Cdx2 gene silencing of recombinant lentivirus particles (Cdx2-RNAi-LV) on expression of Survivin and C-myc in human gastric cancer SGC-7901/DDP resistant cells transplanted subcutaneously in nude mice. Methods The subcutaneous transplantated tumor models in nude mice were established with cell line SGC-7901/DDP of human gastric cancer. The 36 of model mice were randomly divided into 3 groups (n = 12) : PBS group, LV-RNAi group, C dx2-RNAi-LV group, each group of tumors were respectively injected with phosphate buffer, the lentivirus particles (0. 5 ×10^8 TU/ml), containing Cdx2 gene recombinant lentiviral particles (0. 5 ×10^8TU/ml) , the corresponding volume of drugs which were all equivalent 100 μl, once every three days for six times. And all mice were intraperitoneally injected with the drug cisplatin (25 mg/kg), once every two days for ten times. After 20 days, all mice were sacrificed and subcutaneous tumors were taken out. Survivin and C-myc mRNA and protein were detected by semi-quantitative reverse transcription polymerase chain reaction (RT- PCR) and Western blot. Results Among groups of Cdx2-RNAi-LV, LV-RNAi and PBS, the mRNA and protein of Survivin and C-myc were all expressed in cells, but the corresponding expression levels of mRNA and protein in each group cells were not all the same. Compared with LV-RNAi group and PBS group, Survivin and C-myc mRNA and protein were downregulated in Cdx2-RNAi-LV group ( P 〈 0..05 ). However, no significant difference was found be- tween LV-RNAi group and PBS group(P 〉 0.05 ). Conclusion The Cdx2 Gene Silencing of recombinant lentivirus particles intratumorally injected cottld significantly downregulate the expression of Survivin and C-myc in gastric carci- noma transplanted tumor carried by nude mice, and the down-regulation of Survivin and C-myc expression perhaps is one of the Cdx2 gene silencing reversal of tumor resistance mechanisms.
出处 《中国临床新医学》 2013年第2期95-98,共4页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 国家自然科学基金资助项目(编号:81060201) 广西自然科学基金资助项目(编号:2011GXNSFA018273) 广西重大疾病防治新技术研究开发项目(编号:桂科攻1298003-2-6)
关键词 胃癌 慢病毒 CDX2 SURVIVIN C-MYC Gastric cancer Lentivirus Cdx2 Survivin C-myc
  • 相关文献

参考文献4

二级参考文献45

  • 1Zheng, Yao,Wang, Lin,Zhang, Jian-Ping,Yang, Jing-Yan,Zhao, Zhu-Mei,Zhang, Xiao-Ying.Expression of p53,c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma[J].World Journal of Gastroenterology,2010,16(3):339-344. 被引量:34
  • 2詹文华.我国胃癌外科临床研究的现状及方向[J].临床外科杂志,2005,13(8):469-470. 被引量:4
  • 3Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 4文亚渊,付涛,雷英.凋亡相关基因Survivin、Caspase-3、Caspase-9和Cyclin B_1在胃癌组织中的表达[J].消化外科,2006,5(5):364-368. 被引量:3
  • 5Sherwood ER, Van Dongen JL, Wood CG, Liao S, Kozlowski JM, et al. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Br J Cancer 1998; 77: 855-61.
  • 6Davies P, Eaton CL, France TD, Phillips ME. Growth factor receptors and oncogene expression in prostate cells. Am J Clin Oncol 1988; 11 (Suppl 2): S1-7.
  • 7Festuccia C, Gravina GL, Angelucci A, Millimaggi D, Muzi P, et al. Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro. Int J Cancer 2005; 115: 630-40.
  • 8Eder IE, Bektic J, Haag P, Bartsch G, Klocker H. Genes differentially expressed in prostate cancer. BJU Int 2004; 93: 1151-5.
  • 9Katner AL, Hoang QB, Gootam P, Jaruga E, Ma Q, et al. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27 (Kipl). Prostate 2002; 53: 77-87.
  • 10Ye D, Mendelsohn J, Fan Z. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kipl and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells. Clin Cancer Res 1999; 5: 2171-7.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部